The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Accelerated leukemic transformation after haplo-identical transplantation for hydroxyurea-treated sickle cell disease
Abstract
Currently available therapeutic options for the treatment of SCD consists of Hydroxyurea, red cells transfusion and hematopoietic stem cell transplantation (HSCT). HSCT is the only curative option,...
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This may also be relevant to other transplantation settings as blood cancers have also been reported in patients with SCD treated with HCT48–54.”
From Clonal selection of hematopoietic stem cells after gene therapy for sickle cell disease (2023) · cites this paper as [51]
Citations
Cites
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
Wong, T. N., Ramsingh, G., Young, A. L., Miller, C. A., Touma, W., Welch, J. S., Lamprecht, T. L., Shen, D., Hundal, J., Fulton, R. S., et al. (2015) · Nature · doi:10.1038/nature13968 · Cited by 892
Research works printed but not linked: 14
- 10.1182/blood.V126.23.541.541 · DOI
- 10.1111/bjh.14167 · DOI
- 10.1182/blood-2012-08-448068 · DOI
- 10.1038/sj.leu.2401298 · DOI
- 10.1182/blood-2012-07-438408 · DOI
- 10.2147/JBM.S60515 · DOI
- 10.1182/blood.V95.11.3589.011k38_3589_3593 · DOI
- 10.1182/blood-2009-05-221333 · DOI · Paper page
- 10.7326/0003-4819-155-10-201111150-00024 · DOI
- 10.7326/0003-4819-133-11-200012050-00029 · DOI
- 10.1002/ajh.21699 · DOI · Paper page
- 10.1002/ajh.10427 · DOI
- 10.4137/CMO.S8810 · DOI
- 10.1046/j.1365-2141.2003.04614.x · DOI
Cited by
Hsieh, M. M., Bonner, M., Pierciey, F. J., Uchida, N., Rottman, J., Demopoulos, L., Schmidt, M., Kanter, J., Walters, M. C., Thompson, A. A., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019001330 · Cited by 152
Clonal selection of hematopoietic stem cells after gene therapy for sickle cell disease
Spencer Chapman, M., Cull, A. H., Ciuculescu, M. F., Esrick, E. B., Mitchell, E., Jung, H., O’Neill, L., Roberts, K., Fabre, M. A., Williams, N., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02636-6 · Cited by 67
Metadata
- Authors
- Janakiram, M., Verma, A., Wang, Y., Budhathoki, A., Suarez Londono, J., Murakhovskaya, I., Braunschweig, I., & Minniti, C. P.
- Venue
- Leukemia & Lymphoma
- Publisher
- Informa UK Limited
- Published
- 2017-06-07
- Volume
- 59
- Issue
- 1
- Pages
- 241-244
- ISSN
- 1042-8194
- 1029-2403
- Cited by
- 20
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
